CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

DSIJ Intelligence
/ Categories: Trending, Markets

Overnight Digest: Stocks to look out for on September 18

The stocks that are likely to witness significant movement on the bourses on September 18 are Indraprastha Gas, Alembic Pharmaceuticals, Avenue Supermarts, IL&FS Transportation Networks Limited and SMS Lifesciences. 


Indraprastha Gas: The company has been granted authorisation for development of city gas distribution network in Meerut, Muzaffarnagar and Shamli districts. The stock will be watched on Tuesday. 


Alembic Pharmaceuticals : The company  has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) desvenlafaxine extended release tablets, 25 mg., indicated for the treatment of major depressive disorder. The share will be in focus on Tuesday’s trading session. 


Avenue Supermarts: The company has raised funds worth Rs 70 crore through issuance of commercial paper. Due to this, the stock of the company is likely to be in focus on Tuesday’s trading session. 


IL&FS Transportation Networks Limited: The debt-laden IL&FS, which was in the news for all negative reasons, has informed the bourses that the company today paid the interest due on non-convertible debentures (NCDs). The stock will be watched on Tuesday. 


SMS Lifesciences India: The company has further acquired 10,00,000 equity shares of Rs 10 each (21.21%) in Mahi Drugs. With this, the total stake of the company as on date in Mahi Drugs is 100.00% and the latter has become a wholly-owned subsidiary of the company. The shares of the company will be in the limelight tomorrow. 

Previous Article Tata Elxsi announces partnership, stock ends in green
Next Article Markets set to open lower due to rising global trade war concerns
Print
1466 Rate this article:
3.3
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR